CN102653743A - Thermal stability improved lipase mutant constructed through orthogenesis - Google Patents

Thermal stability improved lipase mutant constructed through orthogenesis Download PDF

Info

Publication number
CN102653743A
CN102653743A CN2012101455039A CN201210145503A CN102653743A CN 102653743 A CN102653743 A CN 102653743A CN 2012101455039 A CN2012101455039 A CN 2012101455039A CN 201210145503 A CN201210145503 A CN 201210145503A CN 102653743 A CN102653743 A CN 102653743A
Authority
CN
China
Prior art keywords
lipase mutant
lipase
thr
ser
mutant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN2012101455039A
Other languages
Chinese (zh)
Other versions
CN102653743B (en
Inventor
喻晓蔚
徐岩
王睿
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jinhu agricultural and sideline products Marketing Association
Original Assignee
Jiangnan University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jiangnan University filed Critical Jiangnan University
Priority to CN 201210145503 priority Critical patent/CN102653743B/en
Publication of CN102653743A publication Critical patent/CN102653743A/en
Application granted granted Critical
Publication of CN102653743B publication Critical patent/CN102653743B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Abstract

The invention relates to a thermal stability improved lipase mutant constructed through orthogenesis, belonging to the technical field of enzymatic genetic engineering. The invention discloses a thermal stability improved lipase mutant obtained through a molecular biological technology by using a Rhizopuschinensis CCTCCM201021 lipase as a parent. In amino acid sequences of each mutant, the related amino acid mutant is one or more of Met101Thr, Glu107Gly, Ala129Ser, Ser151Asn, Cys160Leu, Lys161Arg, Pro168Leu, Pro168His, Leu180His, Asp182Tyr, Thr183Ala, Thr218Ser, Lys219Asp, Ala230Phe, Ser234Phe, Val261Gly, His317Pro, Val329Ala, Glu363Arg, Asn366Asp and Ser373Cys. The mutants are represented by a half-life period of t50 at 65 DEG C, and the thermal stability of the mutants are improved compared with the parent of Rhizopuschinensis lipase. The invention also discloses a DNA (Deoxyribonucleic Acid) sequence, an expression vector and a host cell for encoding the lipase mutant.

Description

The lipase mutant that the thermostability that makes up through orthogenesis improves
Technical field
The lipase mutant that the thermostability that the present invention relates to make up through orthogenesis improves relates in particular to and utilizes Protocols in Molecular Biology to obtain the lipase mutant that thermostability improves, and belongs to the gene engineering technology field of enzyme.
Background technology
Lypase (EC 3.1.1.3) can not only catalyzing oil hydrolysis by using, also can be in nonaqueous phase reactions such as synthetic, the transesterificationization of catalysis ester, acidolysis, be widely used in chemistry, food is in pharmacy and washing composition or the bioenergy industry.Mikrobe is an important source of lypase, and head mold is the important production bacterium of microbial lipase.Nowadays, existingly surpass 30 kinds of rizolipases and realized commercialization production.Rizolipase mostly has height 1, and therefore the 3-regioselectivity is usually used in the grease processing.But grease processing need be carried out under comparatively high temps usually, and rizolipase belong in warm lypase, only have about 15 min in the transformation period under 65 ℃, poor heat stability has not only limited its range of application, and is easy to inactivation, has increased production cost.
Orthogenesis belongs to irrational design; Be meant through simulation Darwin nature evolutionary process in the laboratory, to the gene of a certain protein enzyme, the gene of the enzyme of transforming through improved induced-mutation technique; According to specific transformation purpose, screen valuable natural enzyme then.Over nearly 10 years; The orthogenesis technology obtains great success at esterase and lypase character transformation field, mainly concentrates on the catalytic reaction activity that improves enzyme, improves substrate specificity; Improve thermostability, aspects such as enantio-selectivity (Johannes TW et al. Curr. Opin. Microbiol, 2006,9:261-267).
The contriver in early-stage Study, successfully from the distiller's yeast of brewing aroma type yeast wine, screen a plant height yielding lipase zhizopchin ( Rhizopus chinensis) CCTCC M 201021 bacterial strains, and from this bacterial strain first clone obtain lipase gene sequence, and realize this lypase pichia pastoris phaff ( Pichia pastoris) in high-level secretory expression (Yu Xiao-Wei et al. J Mol Catal B:Enzym, 2009,57:304-311).The present invention is a template with the zhizopchin lipase gene, utilizes the orthogenesis technology to obtain the lipase mutant that thermostability significantly improves.
The thermostability of enzyme molecule improves can use its transformation period (t 50) embody.The vigor that is enzyme is reduced to the original needed time of vigor one half.Long half time, then enzyme stability is high.Otherwise, poor stability then.Therefore, t 50Raising represented the raising of enzyme molecular heat stability.
Definition:
The nomenclature of amino acid and DNA nucleotide sequence
Use the generally acknowledged IUPAC nomenclature of amino-acid residue, use the trigram code form.The DNA nucleotide sequence adopts generally acknowledges the IUPAC nomenclature.
The sign of lipase mutant
Adopt " amino acid of original amino acid position replacement " to represent the amino acid that suddenlys change in the lipase mutant.Like Glu107Gly, the amino acid of expression position 107 replaces to Gly by the Glu of parent lipase, and the numbering of position is corresponding to the aminoacid sequence numbering of parent's zhizopchin lypase RCL in the annex sequence table 1.
Like Leu180His/ Thr218Ser, sudden change has all taken place in the amino acid of expression position 180 and position 218.
Summary of the invention
The object of the present invention is to provide the lipase mutant of the thermostability raising that makes up through orthogenesis.
Technical scheme of the present invention: the lipase mutant that the thermostability that makes up through orthogenesis improves, by parent's zhizopchin ( Rhizopus chinensis) CCTCC M 201021 lypase carry out orthogenesis; Through fallibility PCR, DNA Shuffling and rite-directed mutagenesis; Obtain lipase mutant, undergo mutation in the aminoacid replacement position among parent's zhizopchin aminoacid sequence SEQ ID NO:1, adopt " amino acid of original amino acid-position-replacement " to represent the amino acid that suddenlys change in the lipase mutant; Said lipase mutant is:
Table 1
Figure 340786DEST_PATH_IMAGE001
The aminoacid sequence of zhizopchin lypase amino acid mutation body is SEQ ID NO:2, and 22 mutating acids are arranged, and the background color mark shows.
The expression vector that is used to express described lipase mutant is: pPIC9K, pPIC3.5K, pPICZ α, pPICZ;
Being used for described expression vector microorganism transformed host cell is pichia spp.
Compare with parent's zhizopchin lypase, the thermostability of said lipase mutant has obtained raising, with the transformation period under 65 ℃ t 50Represent the raising of thermostability, the transformation period of said lipase mutant and the multiple of raising are following:
Table 2
Figure 943412DEST_PATH_IMAGE002
The transformation period of parent's zhizopchin lypase under 65 ℃ t 50Be 16.5 min.
Beneficial effect of the present invention: the utilization molecular biology method carries out orthogenesis to parent's zhizopchin lypase, through fallibility PCR, DNA Shuffling and rite-directed mutagenesis, obtains lipase mutant, with transformation period t 50Expression, the thermostability of lipase mutant is improved, and is as shown in table 2.
Description of drawings
Confirm mutating acid according to Shanghai Sangon Biological Engineering Technology And Service Co., Ltd's sequencing result, the amino acid mutation site sequencing result of each two mutants is following.
Fig. 1 lipase mutant 1:Ser234Phe peak figure that checks order.
Fig. 2 lipase mutant 2:a:Pro168Leu, the b:Val329Ala peak figure that checks order.
Fig. 3 lipase mutant 3:Cys160Leu peak figure that checks order.
Fig. 4 lipase mutant 4:a:His317Pro, the b:Met101Thr peak figure that checks order.
Fig. 5 lipase mutant 5:a:Ser151Asn, the b:Leu180His peak figure that checks order.
Fig. 6 lipase mutant 6:a:Val261Gly, the b:Ser373Cys peak figure that checks order.
Fig. 7 lipase mutant 7:a:Asp182Tyr, the b:Ala230Phe peak figure that checks order.
Fig. 8 lipase mutant 8:a:Leu180His, the b:Thr218Ser peak figure that checks order.
Fig. 9 lipase mutant 9:a:Asn366Asp, b:Leu180His, the c:Val329Ala peak figure that checks order.
Figure 10 lipase mutant 10:a:Ser234Phe, b:Leu180His, the c:Thr218Ser peak figure that checks order.
Figure 11 lipase mutant 11:a:Ser234Phe, b:Pro168 His, c:Val329Ala, d:Cys160Leu, e:His317Pro, the f:Met101Thr peak figure that checks order.
Figure 12 lipase mutant 12:a:Leu180His, b:Thr218Ser, c:Val261Gly, the d:Lys161Arg peak figure that checks order.
Figure 13 lipase mutant 13:a:Glu107Gly, b:Ala129Ser, C:Glu363Arg, d:Lys161Arg, e:Val261Gly, the f:Leu180His peak figure that checks order.
Figure 14 lipase mutant 14:a:Lys161Arg, b:Leu180His, c:Thr218Ser, d:Met101Thr, e:Thr183Ala, f:Glu107Gly, g:Ser151Asn, the h:Glu363Arg peak figure that checks order.
Figure 15 lipase mutant 15:a:Glu107Gly, b:Ala129Ser, c:Ser151Asn, d:Lys161Arg, e:Leu180His, f:Ser234Phe, g:Glu363Arg, the h:Val329Ala peak figure that checks order.
Figure 16 lipase mutant 12-1:a:Ala230Phe, b:Leu180His, c:Thr218Ser, d:Val261Gly, the e:Lys161Arg peak figure that checks order.
Figure 17 lipase mutant 13-1:a:Glu107Gly, b:Ala129Ser, c:Ser151Asn, d:Lys219Asp, e:Leu180His, f:Glu363Arg, the g:Ala230Phe peak figure that checks order.
Embodiment
The substratum and the agent prescription that relate among the embodiment are following:
The LB liquid nutrient medium: peptone 1%, yeast extract 0.5%, NaCl 1%, pH7.0.
YPD (Yeast Extract Peptone Dextrose Medium): Yeast Extract 1%, Trypton 2%, and Dextrose 2%, adds Agar 2% when making flat board.121 ° of C autoclaving 20 min.Adding G418 when being used to screen the G418 resistance is 0.25 mg/mL-1.0 mg/mL to final concentration, and promptly YPD-G418 is dull and stereotyped.
MD(Minimal?Dextrose?Medium):?YNB?1.34％,?Biotin?4×10 -5％,?Dextrose?2％,?Agar?2％。
MM(Minimal?Methanol?Medium):?YNB1.34％,?Biotin4×10 -5％,?Methanol?0.5％,?Agar2％。
BMGY (Buffered Glycerol-complex Medium): Yeast Extract 1%, Trypton 2%, and YNB 1.34%, and Biotin 4 * 10 -5%, Glycerol 1%, potassium phosphate solution pH 6.0,100 mmol/L.
BMMY (Buffered Methanol-complex Medium): Yeast Extract 1%, Trypton 2%, YNB1.34%, Biotin 4 * 10 -5%, Methanol 0.5%, potassium phosphate solution 100 mmol/L.
Unit in the substratum is % (W/V)
Fast-blue RR staining agent: 360 μ L naphthalene esters (20mg naphthalene ester is dissolved in 1mL 2-NMF) mix with 160 μ L Fast blue RR (80mg Fast blue RR is dissolved in the 1mL methyl-sulphoxide) mutually.
Embodiment 1, utilize the pichia spp library of fallibility PCR method construction expression lipase mutant
Utilize the fallibility round pcr to introduce coding mutation to zhizopchin lipase gene proRCL external.The reaction conditions of fallibility PCR is following:
Wherein, upstream primer F and downstream primer R sequence are:
F:?5'-TCAAGATCCCTAGGGTTCCTGTTGGTCATAAAGGTTC-3';
R:?5'-AATTCCAGTGCGGCCGCTTACAAACAGCTTCCTTCG-3'。
Pcr amplification condition: 94 ℃ of 3min; 94 ℃ of 1 min, 59 ℃ of 1 min, 72 ℃ of 2 min, 30 circulations; 72 ℃ of 10 min.
The fallibility pcr amplification product behind DNA purification kit purifying, restriction enzyme AvrII with NotI digests fallibility pcr amplification product and plasmid pPIC9K respectively, connects, and obtains to comprise the expression plasmid of mutant gene, is converted into E .coliThe JM109 competent cell.Coat LB (Amp that contains 100 μ g/ μ L) flat board.Grow behind 12 h, transformant is transferred in the LB liquid nutrient medium cultivates, obtain expression plasmid.
With expression plasmid through restriction enzyme SalAfter the I linearizing, electricity transforms pichia spp GS115 competent cell.Conversion fluid is coated on the MD flat board, and 30 ° of C cultivate 2 d, constitute the pichia spp library of expressing lipase mutant.
Embodiment 2, utilize the pichia spp library of DNA Shuffling method construction expression lipase mutant
Utilize the method for DNA Shuffling that the mutational site in the lipase mutant of fallibility PCR structure is made up at random.The condition of DNA Shuffling is following:
Extract Be prone toThe genome in the pichia spp library of the expression lipase mutant that wrong PCR method makes up is with DNase I digestion 30min, with being dissolved in the 30 μ L sterilized waters behind the digestion product phenol chloroform extrct deproteinize.With this genome is that template is operated as follows:
Step 1: PCR reaction system:
Taq (2.5U) 0.5 μL
5×buffer（Mg 2+ plus） 10 μL
Genome 0.5 μL
dNTP(25mmol/L) 4 μL
dd H 2O 34.5 μL
Pcr amplification condition: 94 ℃ of 3min; 94 ℃ of 1 min, 59 ℃ of 1 min, 72 ℃ of 2 min, 10 circulations; 72 ℃ of 10 min.
Step 2: in above-mentioned system, add primers F and each 1 μ L of R, pcr amplification condition: 94 ℃ of 3min; 94 ℃ of 1 min, 59 ℃ of 1 min, 72 ℃ of 2 min, 30 circulations; 72 ℃ of 10 min.
Amplified production is after glue reclaims the purification kit purifying, with the same method of embodiment 1, the pichia spp library of construction expression lipase mutant.
The screening of embodiment 3, high enzyme lipase mutant alive
Xerox and to copy on the MM flat board being stored in pichia spp library on the MD flat board, cultivated 2 days for 30 ℃, with the pichia spp of expressing parent's zhizopchin lypase as the contrast bacterium.
Dull and stereotyped primary dcreening operation: per 12 h cover to the MM plate and add the expression of 200 μ L methanol induction recombinant lipases; After inducing 2-3 days; Flat board is placed 65 ℃ of thermal treatment 60 min; Cool to room temperature is evenly toppled over about 15 mL of Fast-blue RR staining agent on flat board, in 2 min mono-clonal the apparent chocolate bacterium colony that is deeper than contrast be primary dcreening operation purpose bacterial strain.
96 orifice plate screening methods: in 96 orifice plates in 1.8 mL/ holes (flat), add 300 μ L BMGY substratum, 121 ℃ of sterilization 20 min.To wherein inserting the bacterial strain that primary dcreening operation obtains, as the contrast bacterium, 30 ℃ of 250 r/min shaking culture is to OD with the pichia spp of expressing parent's zhizopchin lypase 600Be 2-6.Centrifugal, abandon supernatant, with the resuspended thalline of 900 μ L BMMY substratum, per 24 h add 1 % (V/V) methanol induction lypase to express, and induces 4 days, and centrifugal collection supernatant is measured the transformation period of lipase mutant under 65 ℃ according to the method for embodiment 4 t 50
The pichia spp library of the expression lipase mutant that screening fallibility PCR and DNA Shuffling make up; Obtain the bacterial strain that 14 strain thermostabilitys obviously improve respectively; Measure lypase nucleotide sequence (by Shanghai Sangon Biological Engineering Technology And Service Co., Ltd's order-checking); Utilize triplet codon to infer the aminoacid sequence of lypase, the aminoacid replacement and the transformation period of lipase mutant are as shown in table 3.
Table 3 lipase mutant and transformation period thereof
Figure 56042DEST_PATH_IMAGE005
Embodiment 4 lipase mutants t 50Measure
For measuring lypase t 50Value need be carried out separation and purification to enzyme.
Shake flask fermentation: inoculum size 10% (V/V), in the 25 mL BMGY substratum, 30 ℃ of shaking culture 16～20 h to OD 600Be 2～6, centrifugal collection thalline is diluted to OD with the BMMY substratum 600Be 1, whenever add the methanol induction expression of 0.5 %, behind the cultivation 3-4 d, collect fermented supernatant fluid at a distance from 24 h.
Separation and purification: the fermented supernatant fluid of mutant strain is concentrated through 10 KD ultra-filtration membranes, obtain the sudden change lipase activity component of purifying behind SP-Sepharose FF strong cation exchange chromatography and the Phenyl-Sepharose 6 FF HC column chromatographies.Concrete operations reference Yu Xiao-Wei et al. J Mol Catal B:Enzym, 2009,57:304-311.
t 50Measuring method:
The measuring method of lipase activity is pNPP method (Pencreach G et al. Enzyme and Microbial Technol.1996,18:417-422.).Enzyme is lived is defined as pH8.0,40 ℃ down the reaction PM enzyme amount that produces 1 μ mol p-NP be the lipase hydrolysis enzyme iu of living.Lypase at the measuring method of 65 ℃ of half-life is: at 65 ℃ of following treat enzyme liquid, at the different treatment time sampling, the pNPP method is measured lypase remnant enzyme activity per-cent (%).Log value with remnant enzyme activity per-cent is mapped to time T (min), and the collinear slope is the inactivation constant k InactBy t 50=ln2/ k InactObtain lypase under this temperature t 50
The gene mutation site of embodiment 5 rite-directed mutagenesis combined lipase two mutants
Through the structure in above-mentioned fallibility PCR and DNA Shuffling sudden change library, screening obtains lipase mutant as shown in table 3.Reach the influence of the combination of each sudden change in order to investigate wherein some sudden changes to the lipase mutant vigor; Rite-directed mutagenesis combination (rite-directed mutagenesis can utilize commercially available test kit to carry out) is carried out in mutational site in the his-and-hers watches 3; The gene that will contain the said mutation Sites Combination is connected with carrier pPIC9K; Obtain expression plasmid, follow-up Pichia anomala expression such as embodiment 1 are said.Measure lipase mutant under 65 ℃ with the method for embodiment 4 t 50The lipase mutant that the thermostability acquisition improves is as shown in table 4.
Table 4 two mutants lypase and t 50The multiple that improves
Each lypase title Mutational site and combination thereof Under 65 ℃ t 50 (min) t 50The multiple that improves
Parent lipase - 16.5 1.0
Two mutants 12-1 Ala230Phe/Leu180His/Thr218Ser/Val261Gly/ Lys161Arg 755 45.76
Two mutants 13-1 Glu107Gly/Ala129Ser/Ser151Asn/Lys219Asp/Leu180His/Glu363Arg/Ala230Phe 690 41.82
At last, what note also is, above-mentioned that enumerate only is several embodiment of the present invention.Obviously, the invention is not restricted to above embodiment.
<210> SEQ?ID?NO:?1
<211> 389
<212> PRT
<213>Zhizopchin ( Rhizopus chinensis) CCTCC M 201021 lypase amino acid
 
<400> 1
Met?Val?Ser?Phe?Ile Ser?Ile?Ser?Gln?Gly Val?Ser?Leu?Cys?Leu
5 10 15
Leu?Val?Ser?Ser?MET MET?Leu?Gly?Ser?Ser Ala?Val?Pro?Val?Ala
20 25 30
Gly?His?Lys?Gly?Ser Val?Lys?Ala?Thr?Asn Gly?Thr?Asp?Phe?Gln
35 40 45
Leu?Pro?Pro?Leu?Ile Ser?Ser?Arg?Cys?Thr Pro?Pro?Ser?His?Pro
50 55 60
Glu?Thr?Thr?Gly?Asp Pro?Asp?Ala?Glu?Ala Tyr?Tyr?Ile?Asn?Lys
65 70 75
Ser?Val?Gln?Trp?Tyr Gln?Ala?His?Gly?Gly Asn?Tyr?Thr?Ala?Leu
80 85 90
Ile?Lys?Arg?Asp?Thr Glu?Thr?Val?Gly?Gly Met?Thr?Leu?Asp?Leu
95 100 105
Pro?Glu?Asn?Pro?Pro Pro?Ile?Pro?Ala?Thr Ser?Thr?Ala?Pro?Ser
110 115 120
Ser?Asp?Ser?Gly?Glu Val?Val?Thr?Ala?Thr Ala?Ala?Gln?Ile?Lys
125 130 135
Glu?Leu?Thr?Asn?Tyr Ala?Gly?Val?Ala?Ala Thr?Ala?Tyr?Cys?Arg
140 145 150
Ser?Val?Val?Pro?Gly Thr?Lys?Trp?Asp?Cys Lys?Gln?Cys?Leu?Lys
155 160 165
Tyr?Val?Pro?Asp?Gly Lys?Leu?Ile?Lys?Thr Phe?Thr?Ser?Leu?Leu
170 175 180
Thr?Asp?Thr?Asn?Gly Phe?Ile?Leu?Arg?Ser Asp?Ala?Gln?Lys?Thr
185 190 195
Ile?Tyr?Val?Thr?Phe Arg?Gly?Thr?Asn?Ser Phe?Arg?Ser?Ala?Ile
200 205 210
Thr?Asp?MET?Val?Phe Thr?Phe?Thr?Lys?Tyr Ser?Pro?Val?Lys?Gly
215 220 225
Ala?Lys?Val?His?Ala Gly?Phe?Leu?Ser?Ser Tyr?Asn?Gln?Val?Val
230 235 240
Lys?Asp?Tyr?Phe?Pro Val?Val?Gln?Asp?Gln Leu?Thr?Ala?Tyr?Pro
245 250 255
Asp?Tyr?Lys?Val?Ile Val?Thr?Gly?His?Ser Leu?Gly?Gly?Ala?Gln
260 265 270
Ala?Leu?Leu?Ala?Gly Met?Asp?Leu?Tyr?Gln Arg?Glu?Lys?Arg?Leu
275 280 285
Ser?Pro?Lys?Asn?Leu Ser?Ile?Tyr?Thr?Val Gly?Cys?Pro?Arg?Val
290 295 300
Gly?Asn?Asn?Ala?Phe Ala?Tyr?Tyr?Val?Asp Ser?Thr?Gly?Ile?Pro
305 310 315
Phe?His?Arg?Thr?Val His?Lys?Arg?Asp?Ile Val?Pro?His?Val?Pro
320 325 330
Pro?Gln?Ala?Phe?Gly Tyr?Leu?His?Pro?Gly Val?Glu?Ser?Trp?Ile
335 340 345
Lys?Glu?Asp?Pro?Ala Asp?Val?Gln?Ile?Cys Thr?Ser?Asn?Ile?Glu
350 355 360
Thr?Lys?Glu?Cys?Ser Asn?Ser?Ile?Val?Pro Phe?Thr?Ser?Ile?Ala
365 370 375
Asp?His?Leu?Thr?Tyr Phe?Gly?Ile?Asn?Glu Gly?Ser?Cys?Leu
380 385 389
 
<210> SEQ?ID?NO:?2
<211> 389
<212> PRT
<213>Zhizopchin ( Rhizopus chinensis) CCTCC M 201021 lypase amino acid mutation bodies
Lypase amino acid mutation site: 20 mutating acid background color marks show.
<400> 2
Met?Val?Ser?Phe?Ile Ser?Ile?Ser?Gln?Gly Val?Ser?Leu?Cys?Leu
5 10 15
Leu?Val?Ser?Ser?Met Met?Leu?Gly?Ser?Ser Ala?Val?Pro?Val?Ala
20 25 30
Gly?His?Lys?Gly?Ser Val?Lys?Ala?Thr?Asn Gly?Thr?Asp?Phe?Gln
35 40 45
Leu?Pro?Pro?Leu?Ile Ser?Ser?Arg?Cys?Thr Pro?Pro?Ser?His?Pro
50 55 60
Glu?Thr?Thr?Gly?Asp Pro?Asp?Ala?Glu?Ala Tyr?Tyr?Ile?Asn?Lys
65 70 75
Ser?Val?Gln?Trp?Tyr Gln?Ala?His?Gly?Gly Asn?Tyr?Thr?Ala?Leu
80 85 90
Ile?Lys?Arg?Asp?Thr Glu?Thr?Val?Gly?Gly Thr?Thr?Leu?Asp?Leu
95 100 105
Pro?Gly?Asn?Pro?Pro Pro?Ile?Pro?Ala?Thr Ser?Thr?Ala?Pro?Ser
110 115 120
Ser?Asp?Ser?Gly?Glu Val?Val?Thr?Ser?Thr Ala?Ala?Gln?Ile?Lys
125 130 135
Glu?Leu?Thr?Asn?Tyr Ala?Gly?Val?Ala?Ala Thr?Ala?Tyr?Cys?Arg
140 145 150
Asn?Val?Val?Pro?Gly Thr?Lys?Trp?Asp?Leu Arg?Gln?Cys?Leu?Lys
155 160 165
Tyr Val Leu or His Asp Gly Lys Leu Ile Lys Thr Phe Thr Ser Leu His
170 175 180
Thr?Tyr?Ala?Asn?Gly Phe?Ile?Leu?Arg?Ser Asp?Ala?Gln?Lys?Thr
185 190 195
Ile?Tyr?Val?Thr?Phe Arg?Gly?Thr?Asn?Ser Phe?Arg?Ser?Ala?Ile
200 205 210
Thr?Asp?Met?Val?Phe Thr?Phe?Ser?Asp?Tyr Ser?Pro?Val?Lys?Gly
215 220 225
Ala?Lys?Val?His?Phe Tyr?Phe?Leu?Phe?Ser Tyr?Asn?Gln?Val?Val
230 235 240
Lys?Asp?Tyr?Phe?Pro Val?Val?Gln?Asp?Gln Leu?Thr?Ala?Tyr?Pro
245 250 255
Asp?Tyr?Lys?Val?Ile Gly?Thr?Gly?His?Ser Leu?Gly?Gly?Ala?Gln
260 265 270
Ala?Leu?Leu?Ala?Gly Met?Asp?Leu?Tyr?Gln Arg?Glu?Lys?Arg?Leu
275 280 285
Ser?Pro?Lys?Asn?Leu Ser?Ile?Tyr?Thr?Val Gly?Cys?Pro?Arg?Val
290 295 300
Gly?Asn?Asn?Ala?Phe Ala?Tyr?Tyr?Val?Asp Ser?Thr?Gly?Ile?Pro
305 310 315
Phe?Pro?Arg?Thr?Val His?Arg?Arg?Asp?Ile Val?Pro?His?Ala?Pro
320 325 330
Pro?Gln?Ala?Phe?Gly Tyr?Leu?His?Pro?Gly Val?Glu?Ser?Trp?Ile
335 340 345
Lys?Glu?Asp?Pro?Ala Asp?Val?Gln?Ile?Cys Thr?Ser?Asn?Ile?Glu
350 355 360
Thr?Lys?Arg?Cys?Ser Asp?Ser?Ile?Val?Pro Phe?Thr?Cys?Ile?Ala
365 370 375
Asp?His?Leu?Thr?Tyr Phe?Gly?Ile?Asn?Glu Gly?Ser?Cys?Leu
380 385 389
 
<210> SEQ?ID?NO:?3
 
<400> 3
F:?5'-TCAAGATCCCTAGGGTTCCTGTTGGTCATAAAGGTTC-3';
R:?5'-AATTCCAGTGCGGCCGCTTACAAACAGCTTCCTTCG-3'。

Claims (2)

1. the lipase mutant that the thermostability that makes up through orthogenesis improves, it is characterized in that by parent's zhizopchin ( Rhizopus chinensis) CCTCC NO:M 201021 lypase carry out orthogenesis; Through fallibility PCR, DNA Shuffling and rite-directed mutagenesis; Obtain lipase mutant; Undergo mutation in the aminoacid replacement position among parent's zhizopchin aminoacid sequence SEQ ID NO:1, adopt " amino acid of original amino acid-position-replacement " to represent the amino acid that suddenlys change in the lipase mutant, said lipase mutant is:
Lipase mutant aminoacid replacement position
Two mutants 10 Ser234Phe/Leu180His/Thr218Ser
The aminoacid sequence of zhizopchin lypase amino acid mutation body is SEQ ID NO:2;
The expression vector that is used to express described lipase mutant is: pPIC9K, pPIC3.5K, pPICZ α, pPICZ;
Being used for described expression vector microorganism transformed host cell is pichia spp.
2. lipase mutant according to claim 1 is characterized in that comparing with parent's zhizopchin lypase, and the thermostability of said lipase mutant has obtained raising, with the transformation period under 65 ℃ t 50Represent the raising of thermostability, the transformation period of said lipase mutant and the multiple of raising are following:
65 ℃ of t50 of the 65 ℃ of t50 in lipase mutant aminoacid replacement position (min) (min) improve multiple
Two mutants 10 Ser234Phe/Leu180His/Thr218Ser 89.9 5.45
The transformation period of parent's zhizopchin lypase under 65 ℃ t 50Be 16.5 min.
CN 201210145503 2010-08-13 2010-08-13 Thermal stability improved lipase mutant constructed through orthogenesis Active CN102653743B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 201210145503 CN102653743B (en) 2010-08-13 2010-08-13 Thermal stability improved lipase mutant constructed through orthogenesis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 201210145503 CN102653743B (en) 2010-08-13 2010-08-13 Thermal stability improved lipase mutant constructed through orthogenesis

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CN201010254620XA Division CN101974499B (en) 2010-08-13 2010-08-13 Lipase mutants with enhanced thermal stability

Publications (2)

Publication Number Publication Date
CN102653743A true CN102653743A (en) 2012-09-05
CN102653743B CN102653743B (en) 2013-09-18

Family

ID=46729474

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 201210145503 Active CN102653743B (en) 2010-08-13 2010-08-13 Thermal stability improved lipase mutant constructed through orthogenesis

Country Status (1)

Country Link
CN (1) CN102653743B (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015109972A1 (en) * 2014-01-22 2015-07-30 Novozymes A/S Polypeptides with lipase activity and polynucleotides encoding same
CN105200024A (en) * 2015-08-24 2015-12-30 安徽丰原发酵技术工程研究有限公司 Lipase CALB mutant and preparation method and application thereof
WO2017097590A1 (en) * 2015-12-08 2017-06-15 Henkel Ag & Co. Kgaa Lipases with increased thermostability
CN110172455A (en) * 2019-05-31 2019-08-27 江南大学 A kind of lipase mutant and its application in terms of decontamination

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2933330B1 (en) * 2014-02-26 2018-12-26 Jiangnan University New bifunctional lipase mutant and uses thereof in flour product processing

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6017866A (en) * 1994-05-04 2000-01-25 Genencor International, Inc. Lipases with improved surfactant resistance
CN1768135A (en) * 2003-01-30 2006-05-03 印度科学工业研究所 Stable lipase variants
CN101544966A (en) * 2009-04-28 2009-09-30 江南大学 Zymolysis preparation method of recombinant yeast lipase

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6017866A (en) * 1994-05-04 2000-01-25 Genencor International, Inc. Lipases with improved surfactant resistance
CN1768135A (en) * 2003-01-30 2006-05-03 印度科学工业研究所 Stable lipase variants
CN101544966A (en) * 2009-04-28 2009-09-30 江南大学 Zymolysis preparation method of recombinant yeast lipase

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
NIU, WEI-NING; LI, ZHAO-PENG; ZHANG, DA-WEI; 等: "Improved thermostability and the optimum temperature of Rhizopus arrhizus lipase by directed evolution", 《JOURNAL OF MOLECULAR CATALYSIS B-ENZYMATIC》, vol. 43, no. 14, 4 December 2006 (2006-12-04) *
王睿等: "定向进化-易错PCR方法提高华根霉Rhizopus chinensis CCTCC M201021 脂肪酶的活力", 《生物工程学报》, no. 12, 25 December 2009 (2009-12-25) *

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015109972A1 (en) * 2014-01-22 2015-07-30 Novozymes A/S Polypeptides with lipase activity and polynucleotides encoding same
CN105849121A (en) * 2014-01-22 2016-08-10 诺维信公司 Polypeptides with lipase activity and polynucleotides encoding same
US10208297B2 (en) 2014-01-22 2019-02-19 Novozymes A/S Polypeptides with lipase activity and polynucleotides encoding same for cleaning
US10676725B2 (en) 2014-01-22 2020-06-09 Novozymes A/S Polypeptides with lipase activity and polynucleotides encoding same for cleaning
CN105849121B (en) * 2014-01-22 2020-12-29 诺维信公司 Polypeptides having lipase activity and polynucleotides encoding same
CN105200024A (en) * 2015-08-24 2015-12-30 安徽丰原发酵技术工程研究有限公司 Lipase CALB mutant and preparation method and application thereof
CN105200024B (en) * 2015-08-24 2018-09-21 安徽丰原发酵技术工程研究有限公司 Lipase CALB mutant, preparation method and application
WO2017097590A1 (en) * 2015-12-08 2017-06-15 Henkel Ag & Co. Kgaa Lipases with increased thermostability
CN110172455A (en) * 2019-05-31 2019-08-27 江南大学 A kind of lipase mutant and its application in terms of decontamination

Also Published As

Publication number Publication date
CN102653743B (en) 2013-09-18

Similar Documents

Publication Publication Date Title
CN101974499B (en) Lipase mutants with enhanced thermal stability
CN101899427B (en) Lipase mutant with improved activity and built by orthogenesis
CN102653743B (en) Thermal stability improved lipase mutant constructed through orthogenesis
CN103361326B (en) Partial glyceride lipase mutant with improved thermal resistance, mutant plasmid, recombination strain and preparation method
CN108795916A (en) A kind of lysine decarboxylase mutant, its encoding gene and its expression and application
CN102653742B (en) High-temperature resistant rhizopuschinensis lipase mutant
CN102586203B (en) Determinate-evolution-constructed lipase mutant with improved catalysis activity
CN103103206B (en) Alpha-amylase and gene of alpha-amylase, engineering bacteria containing gene and application of engineering bacteria
CN102653741B (en) High-thermal stability rhizopuschinensis lipase
CN102604912B (en) Rhizopuschinensis lipase mutant with high activity
CN102994471B (en) Lipase mutant with increased optimum temperature and application of lipase mutant with increased optimum temperature
CN102604908B (en) Lipase mutant with high catalytic activity
CN109022396A (en) The alpha-amylase mutant and its application that a kind of enzyme activity improves
CN106635941B (en) A kind of thermophilic esterase and its functional verification from Aquifex aeolicus bacterial strain
CN105200024B (en) Lipase CALB mutant, preparation method and application
CN107365755A (en) A kind of novel lipase and its gene, engineering bacteria and preparation method
CN102604911B (en) Rhizopuschinensis lipase mutant with high activity
CN105420220B (en) A kind of aspartic acid albuminoid enzyme and its encoding gene and application
CN102604909B (en) Directed-evolution structured lipase mutant with enhanced catalytic activity
CN112226422B (en) EstWY enzyme mutant with improved activity
CN105368802B (en) A kind of salt tolerant esterase and its encoding gene and application
CN102604910B (en) Lipase mutant with high catalytic activity
CN104762306B (en) A kind of ocean esterase and its encoding gene E32 and application
CN105420214B (en) A kind of alpha-amylase and its encoding gene and application
CN106434512B (en) A kind of thermophilic esterase and its expression from Aquifex aeolicus bacterial strain

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CP02 Change in the address of a patent holder

Address after: 214122 Jiangsu city of Wuxi Province District Liangxi No. 898 South Road 7 layer beam Creek area of food science and Technology Park

Patentee after: Jiangnan University

Address before: Lihu Avenue Binhu District 214122 in Jiangsu province Wuxi City, No. 1800, Jiangnan University Institute of biological engineering

Patentee before: Jiangnan University

CP02 Change in the address of a patent holder
TR01 Transfer of patent right

Effective date of registration: 20201229

Address after: No.33 Hengyang South Road, Jinhu County, Huaian City, Jiangsu Province 211600

Patentee after: Jinhu agricultural and sideline products Marketing Association

Address before: B001, 3rd floor, building 2, Huacheng science and Technology Plaza, Wenchang West Road, Hanjiang District, Yangzhou City, Jiangsu Province 225000

Patentee before: Yangzhou Tianyi Intellectual Property Service Co.,Ltd.

Effective date of registration: 20201229

Address after: B001, 3rd floor, building 2, Huacheng science and Technology Plaza, Wenchang West Road, Hanjiang District, Yangzhou City, Jiangsu Province 225000

Patentee after: Yangzhou Tianyi Intellectual Property Service Co.,Ltd.

Address before: Liangxi District Food Science and Technology Park, 7th floor, South Building, 898 Tongsha Road, Liangxi District, Wuxi City, Jiangsu Province

Patentee before: Jiangnan University

TR01 Transfer of patent right